Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0106 Transporter Info
Gene Name	SLC16A2
Transporter Name	Monocarboxylate transporter 8
Gene ID	6567
UniProt ID	P36021

Post-Translational Modification of This DT
Overview of SLC16A2 Modification Sites with Functional and Structural Information
Sequence	M A L Q S Q A S E E A K G P W Q E A D Q E Q Q E P V G S P E P E S E P E P E P E P E P V P V P P P E P Q P E P Q P L P D P A P L P E L E F E S E R V H E P E P T P T V E T R G T A R G F Q P P E G G F G W V V V F A A T W C N G S I F G I H N S V G I L Y S M L L E E E K E K N R Q V E F Q A A W V G A L A M G M I F F C S P I V S I F T D R L G C R I T A T A G A A V A F I G L H T S S F T S S L S L R Y F T Y G I L F G C G C S F A F Q P S L V I L G H Y F Q R R L G L A N G V V S A G S S I F S M S F P F L I R M L G D K I K L A Q T F Q V L S T F M F V L M L L S L T Y R P L L P S S Q D T P S K R G V R T L H Q R F L A Q L R K Y F N M R V F R Q R T Y R I W A F G I A A A A L G Y F V P Y V H L M K Y V E E E F S E I K E T W V L L V C I G A T S G L G R L V S G H I S D S I P G L K K I Y L Q V L S F L L L G L M S M M I P L C R D F G G L I V V C L F L G L C D G F F I T I M A P I A F E L V G P M Q A S Q A I G Y L L G M M A L P M I A G P P I A G L L R N C F G D Y H V A F Y F A G V P P I I G A V I L F F V P L M H Q R M F K K E Q R D S S K D K M L A P D P D P N G E L L P G S P N P E E P I
PTM type	X-Acetylation X-Phosphorylation X: Amino Acid

Acetylation
Alanine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A2			[1] , [2]
Role of PTM	Potential impacts
Modified Residue	Alanine	Modified Location	2
Experimental Method	Co-Immunoprecipitation
Detailed Description	Acetylation at SLC16A2 Alanine 2 has the potential to affect its expression or activity.
Phosphorylation
Serine	7 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A2			[3] , [4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	5
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Serine 5 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A2			[4] , [5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	8
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Serine 8 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC16A2			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	71
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Serine 71 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC16A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	193
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Serine 193 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC16A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	195
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Serine 195 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC16A2			[8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	267
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Serine 267 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC16A2			[4] , [9]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	532
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Serine 532 has the potential to affect its expression or activity.
Threonine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC16A2			[10] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	80
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Threonine 80 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC16A2			[5] , [11]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	82
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Threonine 82 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC16A2			[11] , [12]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	85
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Threonine 85 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC16A2			[13]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	290
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC16A2 Threonine 290 has the potential to affect its expression or activity.

References
1	Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
2	Comparative large scale characterization of plant versus mammal proteins reveals similar and idiosyncratic N-alpha-acetylation features. Mol Cell Proteomics. 2012 Jun;11(6):M111.015131.
3	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
4	CEP128 Localizes to the Subdistal Appendages of the Mother Centriole and Regulates TGF-beta/BMP Signaling at the Primary Cilium. Cell Rep. 2018 Mar 6;22(10):2584-2592.
5	p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage. Nat Commun. 2018 Mar 9;9(1):1017.
6	An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J Proteomics. 2014 Jan 16;96:253-62.
7	Activation of diverse signalling pathways by oncogenic PIK3CA mutations. Nat Commun. 2014 Sep 23;5:4961.
8	Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell. 2006 Nov 3;127(3):635-48.
9	Proteogenomic integration reveals therapeutic targets in breast cancer xenografts. Nat Commun. 2017 Mar 28;8:14864.
10	Global Landscape and Dynamics of Parkin and USP30-Dependent Ubiquitylomes in iNeurons during Mitophagic Signaling. Mol Cell. 2020 Mar 5;77(5):1124-1142.e10.
11	Phosphoproteomic screening identifies physiological substrates of the CDKL5 kinase. EMBO J. 2018 Dec 14;37(24):e99559.
12	Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells. Oncotarget. 2016 Sep 20;7(38):61229-61245.
13	Extensive crosstalk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci Signal. 2010 Jan 12;3(104):ra2.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence